Responses to crizotinib can occur in c-MET overexpressing nonsmall cell lung cancer after developing EGFR-TKI resistance.

Name: Responses to crizotinib can occur in c-MET overexpressing nonsmall cell lung cancer after developing EGFR-TKI resistance.
Author: Xu, Yanjun

Responses to crizotinib can occur in c-MET overexpressing nonsmall cell lung cancer after developing EGFR-TKI resistance. — المؤلف: Xu, Yanjun — Cancer biology & therapy 20200421

المؤلف: Xu, Yanjun
النشر: Cancer biology & therapy 20200421
الوصف: 145-149 p.
الموضوعات: Carcinoma, Non-Small-Cell Lung؛ Crizotinib؛ Humans؛ Lung Neoplasms؛ Male؛ Middle Aged؛ Protein Kinase Inhibitors؛ Proto-Oncogene Proteins c-met